The at home arrhythmia assessment market is projected to grow from USD 660.0 million in 2026 to USD 1,711.9 million by 2036, at a CAGR of 10.0%. Wearable ECG patches will dominate with a 40.0% market share, while af detection/monitoring will lead the application segment with a 70.0% share.